
Pfizer has received two boosts in oncology as Xalkori gets a new breakthrough therapy designation from the FDA, and its …

Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …

The FDA has granted AstraZeneca’s cancer medicine selumetinib orphan drug designation for the treatment of uveal melanoma. The company will …

Mumbai-based Sun Pharmaceuticals Industries is teaming up with the Israel Institute of Technology Technion to develop new oncology drugs. This …

AstraZeneca has signed a five-year agreement with PatientsLikeMe to give the pharma firm access to the latter’s global network of …
Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …

Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …

Thomas Webb, launch lead for GSK oncology Hong Kong and Macau How did you find your way into your current role? …

Google has filed a patent application for a new cancer-fighting wearable device which it says targets the cells in the …

The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …

Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …

Novartis’ blood cancer drug Jakavi has been given the green light in Europe to treat adult patients with polycythemia vera …

The Department of Health and NHS England are struggling with the demand required to improve its cancer services according to …

Merck’s skin cancer drug Keytruda has become the first drug to be approved through the new Early Access to Medicines …